The epi-r-tm technology produces a polyclonal til product (lyl845) with diverse tumor-reactive clones that have stem-like qualities and anti-tumor function
JOURNAL FOR IMMUNOTHERAPY OF CANCER(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL FOR IMMUNOTHERAPY OF CANCER(2022)